IP Library Granted Patent US 9,682,935
Granted Patent B2
US 9,682,935 · App. 15/110,410 · Granted Jun 20, 2017

Process for preparation of indacaterol or its pharmaceutically acceptable salts

Inventors: Ponnaiah Ravi (Madurai, IN); Praveen Kumar Neela (Hyderabad, IN); Guruswamy Batthini (Hyderabad, IN); Narayana Venugopalarao (Hyderabad, IN); Naresh Dongari (Nalagonda, IN)
Assignee: Davuluri Ramamohan Rao
C07D215/26C07F7/1856
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,682,935
App. No.
15/110,410
Granted
Jun 20, 2017
Kind
B2
Abstract

A novel process the for preparation of Indacaterol or its pharmaceutically acceptable salts and novel intermediates employed in the preparation thereof that is economically significant for large scale.

Claims (24)

1. A process for preparation of Indacaterol free base or its pharmaceutically acceptable salt comprising the steps of:

i) treating the compound of formula II

with the reducing agent to obtain compound of formula III

where L is good leaving group;

ii) treating compound of formula III with silylated protecting reagent to obtain compound of formula IV

where A is silylated protective group;

iii) reacting the compound of formula IV with compound of formula V or its derivatives in the presence of a base

to obtain compound of formula VI,

iv) desilylating compound of formula VI to obtain compound of formula VII

v) debenzylating the compound of formula VII to obtain compound of formula I Indacaterol free base

vi) optionally converting the compound of formula I into its pharmaceutically acceptable salts.

2. A process for the preparation of compound of formula VI

comprising the step of:

i) reacting the compound of formula IV

with compound of formula V or its derivatives in the presence of base,

to obtain compound of formula VI, wherein A is silylated protective group.

3. The process as claimed in claim 1 , wherein reducing agent used in step (i) is R-Methyl CBS.

4. The process as claimed in claim 1 , wherein silylating agent used in step (ii) is tert-Butyldimethylsilyl chloride (TBDMSCl).

5. The process as claimed in claim 1 , wherein base used in step (iii) is N-methyl pyrrolidone.

6. The process as claimed in claim 1 , where in desilylating agent used in step (iv) is tetra-n-butylammonium fluoride.

7. The process as claimed in claim 1 , where in debenzylating agent used in step (v) is palladium with carbon.

8. The process as claimed in claim 1 , where in solvents used in step (i) to step (vi) are methanol, tetrahydrofuran, chloroform, ethyl acetate, methylene dichloride and isopropyl alcohol.

9. The process as claimed in claim 2 , wherein base used in step (i) is N-methyl pyrrolidone.

10. The process as claimed in claim 2 , wherein the reaction in step (i) takes place at a temperature between 95° C. to 100° C.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2016
From: RAVI, PONNAIAH; NEELA, PRAVEEN KUMAR; BATTHINI, GURUSWAMY; VENUGOPALARAO, NARAYANA; DONGARI, NARESH
To: RAO, DAVULURI RAMAMOHAN, MR.
Reel/Frame 039399/0128 →
Priority Claims (1)
IN 116/CHE/2014 · Jan 9, 2014 · national
Continuity (1)
Related Publication 20160326118A1 · Nov 10, 2016